Reaktion #674294

ord-9cb8e80db79d4a148a9bdeb116705f41

Reaktionsgleichung

[Cl-].[NH4+]
NH4Cl
CC(C)(C)OC(=O)N1CC2(CC(OS(C)(=O)=O)C2)C1
tert-butyl 6-((methylsulfonyl)oxy)-2-azaspiro[3.3]heptane-2-carboxylate
Brc1cn[nH]c1
4-bromopyrazole
[H-].[Na+]
NaH
CC(C)(C)OC(=O)N1CC2(CC(n3cc(Br)cn3)C2)C1
tert-butyl 6-(4-bromo-1H-pyrazol-1-yl)-2-azaspiro[3.3]heptane-2-carboxylate
Ausbeute 31.5%

Lösungsmittel

Reaktionsbedingungen

Temperatur
0°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Sonstigethe ice-bath was removed
  2. 2
    workup.ADDITIONwas added in one portion
  3. 3
    workup.STIRRINGThe mixture was stirred at room temperature for 1 h
  4. 4
    workup.WAIT80° C. for 18 hrs
  5. 5
    EinengenThe mixture was concentrated in vacuo
  6. 6
    Sonstigeto give the residue which
  7. 7
    SonstigeThe layers were separated
  8. 8
    ExtraktionThe aqueous phase was extracted with DCM (2×30 mL)
  9. 9
    TrocknenThe combined organic phase was dried over anhydrous Na2SO4
  10. 10
    Einengenconcentrated
  11. 11
    Sonstigeto give the crude residue which
  12. 12
    Sonstigewas purified by CombiFlash (40 g silica gel column, Hexane/EtOAc)

Vorschrift

To a solution of 4-bromopyrazole (111 mg, 0.755 mmol) in DMF (dry, 2.5 mL) was added NaH (60 wt % in oil, 33 mg, 0.82 mmol) in portions at 0° C. under N2. The mixture was stirred at 0° C. for 15 min, the ice-bath was removed. The mixture was stirred at room temperature for 90 min. tert-butyl 6-((methylsulfonyl)oxy)-2-azaspiro[3.3]heptane-2-carboxylate (200 mg, 0.686 mmol) was added in one portion. The mixture was stirred at room temperature for 1 h, then 80° C. for 18 hrs. The mixture was concentrated in vacuo to give the residue which was dissolved in DCM (30 mL). A saturated solution of NH4Cl (30 mL) was added. The layers were separated. The aqueous phase was extracted with DCM (2×30 mL). The combined organic phase was dried over anhydrous Na2SO4 and then concentrated to give the crude residue which was purified by CombiFlash (40 g silica gel column, Hexane/EtOAc) to afford tert-butyl 6-(4-bromo-1H-pyrazol-1-yl)-2-azaspiro[3.3]heptane-2-carboxylate (74 mg, 31%) as a white solid.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US09226923B2uspto-grants-2016_01